TrustCore Financial Services’s Takeda Pharmaceutical TAK Stock Holding History

TrustCore Financial Services’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-433	Closed	-$7K	–	1153
2021 Q2	$7K	Hold	433	–	–	﹤0.01%	806
2021 Q1	$8K	Buy	+433	New	+$7.79K	﹤0.01%	730
2020 Q4	–	Sell	-311	Closed	-$6K	–	952
2020 Q3	$6K	Buy	311 +211	+211%	+$3.84K	﹤0.01%	672
2020 Q2	$2K	Hold	100	–	–	﹤0.01%	812
2020 Q1	$2K	Buy	+100	New	+$1.81K	﹤0.01%	788

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TrustCore Financial Services's TAK Position: Q3 2021 in Review

TrustCore Financial Services sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 433 shares — an estimated $7K sold.

TrustCore Financial Services first reported a position in TAK in Q1 2020 and held it in 5 quarters. The position peaked at $8K in Q1 2021. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

TrustCore Financial Services reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
TrustCore Financial Services sold 433 Takeda Pharmaceutical shares in Q3 2021, an estimated $7K.
TrustCore Financial Services first reported a position in Takeda Pharmaceutical in Q1 2020 and held it in 5 quarters.
TrustCore Financial Services's Takeda Pharmaceutical position peaked at $8K in Q1 2021.
292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on TrustCore Financial Services's 13F filing for Q3 2021, filed 8 Nov 2021.